Bourla and some of his staff have received their first doses but are yet to receive their second. US pharma giant announced the trip's postponement on Thursday.
Pfizer’s CEO, Albert Bourla, revealed he has finally received the first round of a two-dose treatment developed by his pharmaceutical company to protect against COVID-19.